Anticancer effects and potential mechanisms of ginsenoside Rh2 in various cancer types

被引:30
|
作者
Zhang, Haibo [1 ]
Park, Song [2 ]
Huang, Hai [1 ]
Kim, Eungyung [1 ]
Yi, Junkoo [3 ]
Choi, Seong-Kyoon [2 ]
Ryoo, Zaeyoung [4 ]
Kim, Myoungok [1 ]
机构
[1] Kyungpook Natl Univ, Inst Translat Res Dent, Dept Anim Sci & Biotechnol, 80 Daehakro, Bukgu 41566, Daegu, South Korea
[2] Daegu Gyeongbuk Inst Sci & Technol, Core Prot Resources Ctr, Daegu 41566, South Korea
[3] Gyeongsangbukdo Livestock Inst Res, Yeongju 36052, Gyeongsangbukdo, South Korea
[4] Kyungpook Natl Univ, Brain Korea 21 Fostering Outstanding Univ Res Kyu, Sch Life Sci, 80 Daehakro, Daegu 41566, South Korea
关键词
ginsenoside Rh2; Panax ginseng; anticancer; mechanisms; review; CELL-CYCLE ARREST; HUMAN LEUKEMIA-CELLS; 20(S)-GINSENOSIDE RH2; CARCINOMA-CELLS; MOLECULAR-MECHANISMS; LUNG-CANCER; GLIOBLASTOMA-MULTIFORME; ADJUVANT CHEMOTHERAPY; DEPENDENT INHIBITION; HISTONE DEACETYLASE;
D O I
10.3892/or.2021.7984
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ginsenoside Rh2 (G-Rh2) is a natural bioactive product derived from Panax ginseng Meyer (P. ginseng). G-Rh2 exhibits anticancer activity in various human cancer cell lines both in vitro and in vivo by modulating several signaling pathways, such as those of PDZ-binding kinase/T-LAK cell-originated protein kinase, phosphatidylinositol 3-kinase, protein kinase B, mammalian target of rapamycin, epidermal growth factor receptor, p53, and reactive oxygen species. Moreover, G-Rh2 could effectively reverse drug resistance and enhance therapeutic effects in cancer therapy. This review summarizes the chemical properties, in vitro and in vivo anticancer activity, and underlying molecular mechanisms of G-Rh2 to facilitate cancer chemoprevention studies.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Anticancer Effects of Ginsenoside Rh2: A Systematic Review
    He, Xin-Ling
    Xu, Xiao-Huang
    Shi, Jia-Jie
    Huang, Mingqing
    Wang, Yitao
    Chen, Xiuping
    Lu, Jin-Jian
    CURRENT MOLECULAR PHARMACOLOGY, 2022, 15 (01) : 179 - 189
  • [2] Anticancer property of ginsenoside Rh2 from ginseng
    Li, Xun
    Chu, Shifeng
    Lin, Meiyu
    Gao, Yan
    Liu, Yingjiao
    Yang, Songwei
    Zhou, Xin
    Zhang, Yani
    Hu, Yaomei
    Wang, Huiqin
    Chen, Naihong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 203
  • [3] Study on the molecular mechanism of ginsenoside Rh2 anticancer activity
    Jin, Ying-Hua
    Wang, Yushi
    Lin, Yingjia
    Li, He
    Li, Yang
    CANCER SCIENCE, 2018, 109 : 1000 - 1000
  • [4] Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells
    Xi-Ping Tang
    Guo-Du Tang
    Chun-Yun Fang
    Zhi-Hai Liang
    Lu-Yi Zhang
    World Journal of Gastroenterology, 2013, (10) : 1582 - 1592
  • [5] Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells
    Tang, Xi-Ping
    Tang, Guo-Du
    Fang, Chun-Yun
    Liang, Zhi-Hai
    Zhang, Lu-Yi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (10) : 1582 - 1592
  • [6] Potential of ginsenoside Rh2 and its derivatives as anti-cancer agents
    Li, Keke
    Li, Zhongyu
    Men, Lei
    Li, Wei
    Gong, Xiaojie
    CHINESE JOURNAL OF NATURAL MEDICINES, 2022, 20 (12) : 881 - 901
  • [7] Inhibition of prostatic cancer growth by ginsenoside Rh2
    Zhang, Qingchuan
    Hong, Bin
    Wu, Songhua
    Niu, Tianli
    TUMOR BIOLOGY, 2015, 36 (04) : 2377 - 2381
  • [8] The interaction of serum albumin with ginsenoside Rh2 resulted in the downregulation of ginsenoside Rh2 cytotoxicity
    Lin, Yingjia
    Li, Yang
    Song, Zhi-Guang
    Zhu, Hongyan
    Jin, Ying-Hua
    JOURNAL OF GINSENG RESEARCH, 2017, 41 (03) : 330 - 338
  • [9] Antiallergic activity of ginsenoside Rh2
    Park, EK
    Choo, MK
    Kim, EJ
    Han, MJ
    Kim, DH
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2003, 26 (11) : 1581 - 1584
  • [10] Probable Mechanisms of Doxorubicin Antitumor Activity Enhancement by Ginsenoside Rh2
    Popov, Alexander
    Klimovich, Anna
    Styshova, Olga
    Tsybulsky, Alexander
    Hushpulian, Dmitry
    Osipyants, Andrey
    Khristichenko, Anna
    Kazakov, Sergey
    Ahuja, Manuj
    Kaidery, Navneet
    Thomas, Bobby
    Tishkov, Vladimir
    Brown, Abraham
    Gazaryan, Irina
    Poloznikov, Andrey
    MOLECULES, 2022, 27 (03):